01675nam a2200301   4500001000700000010001800007100004100025101000800066200010200074210010700176215002000283300004900303330073700352606002401089606002201113606002401135606002901159606002201188606001301210606001201223606002001235606001401255606001301269606001401282606001901296606001201315710004601327394298  a9789284613473  a20161221d2016       y0pory50      ba  aeng  aA review and assessment of EU drug policybRecurso eletrónicoestudyfMirja Gutheil ...[et al.]  aBrusselscEuropean Parliament. Policy Department for Citizen's Rights and Constitutional Affairsd2016  a1 CD-ROMd12 cm  aFicheiro de 2,41 MB em formato PDF (224 p.).  aExecutive Summary. 1. Introduction and Methodology. 2. International Drug Policy Overview. 3. Eu Legal and Policy Framework. 4. Member State Drug Policies. 5. Effectiveness and Added Value of Drug Policy. 6. Observations, Recommendations and Policy Proposals. References. Appendix A: Eu Case Studies. Appendix A1: Case Study – Czech Republic. Appendix A2: Case Study – Germany. Appendix A3: Case Study – Spain. Appendix A4: Case Study – Netherlands. Appendix A5: Case Study – Poland. Appendix A6: Case Study – Portugal. Appendix A7: Case Study – Sweden. Appendix B: Non-Eu Case Studies. Appendix B1: Case Study – Switzerland. Appendix B2: Case Study – United States Of America. Appendix B3: Case Study – Uruguay.  aTOXICODEPENDÊNCIA  aCOMBATE À DROGA  aPOLÍTICA CRIMINAL  aPOLÍTICA COMUNITÁRIA  aREPÚBLICA CHECA  aALEMANHA  aESPANHA  aPAÍSES BAIXOS  aPOLÓNIA  aSUÉCIA  aSUÍÇA  aESTADOS UNIDOS  aURUGUAI  aA REVIEW AND ASSESSMENT OF EU DRUG POLICY